Aaron Kantoff - Director at Tourmaline Bio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
TRML on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Aaron Kantoff since 11/5/2023

Holdings reported by Aaron Kantoff for Tourmaline Bio, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 45.4K $771K $16.99 Oct 24, 2023 Direct
Stock Option (Right to Buy) 10K Jun 5, 2024 Direct Common Stock

Transactions reported by Aaron Kantoff for Tourmaline Bio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.